The upcoming earnings report for Option Care Health, Inc. (OPCH) is scheduled for Wednesday, April 29th, with a consensus estimate EPS of 0.37.
Option Care Health, Inc. (OPCH) is currently priced at $27.95, showing a price increase of 2.0001 cents (0.072%) from the previous close. Trading volume stands at $283,317, representing a 16.2% increase relative to the average.
In the last quarterly earnings report on Monday, February 23rd, OPCH reported an EPS of 0.46, exceeding the consensus estimate. The latest quarterly revenue figures are pending.
The company witnessed a net change in cash of -$77.20 million, with operating cash flow at $35.89 million. Notably, common stock repurchased stood at -$95 million.
OPCH reported a revenue of $1.47 billion, gross profit of $282.90 million, and net income of $58.5 million in the last period. The EPS and diluted EPS both stood at 37 cents.
Key ratios for OPCH include a net profit margin of 4%, return on equity of 4.41, and a price-to-earnings ratio of 21.53. The quick ratio is at 0.96, indicating a healthy liquidity position.
The balance sheet reflects total assets of $3.46 billion, with total current liabilities at $829.35 million, resulting in a net debt position of -$232.62 million.
This comprehensive snapshot reveals insights into OPCH's financial health and sets the stage for potential market movements ahead of the earnings announcement.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.